Pmgc holdings inc ELAB.US Overview Analysis
ELAB AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
With insufficient quarterly financial data released by the company, we're unable to provide a rating.
ELAB Current Performance
1.28%
Pmgc holdings inc
0.38%
Avg of Sector
-0.07%
S&P500
Top 10 High Relevance to ELAB
- YI 111 inc - adrValue 2Trend 2Swing Trading 2Whale Interest 1Dividend 1See more
ELAB Profile
PMGC Holdings Inc Formerly known as Elevai Labs Inc.. PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. The Company's portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is a research and development subsidiary of the Company, which is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment vehicle engaging in investing, lending, and seeking diversified investment opportunities across various markets.